Related Experiment Video
Updated: May 3, 2026

06:54
MR Molecular Imaging of Prostate Cancer with a Small Molecular CLT1 Peptide Targeted Contrast Agent
Published on: September 3, 2013
11.2K
Response Evaluation Using 68 Ga-DOTA-IBA in a Case of Metastatic Prostate Cancer
Clinical Nuclear Medicine
|January 24, 2025
Abstract:
We report a case of a patient with metastatic prostate cancer receiving first-line endocrine therapy. Clinical symptoms, PSA level, and CT confirmed the significant progression of his bone metastatic lesions. In comparison to images at baseline, follow-up bone scan incorrectly showed remission of the bone lesions, whereas follow-up 68 Ga-DOTA-IBA correctly showed disease progression.

